Onderzoeker
Anje Cauwels
- Disciplines:Palliatieve zorg en zorg rond het levenseinde, Laboratoriumgeneeskunde, Andere translationele wetenschappen, Regeneratieve geneeskunde, Verpleegkunde, Andere klinische wetenschappen, Andere basiswetenschappen, Andere paramedische wetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Vakgroep Biomoleculaire Geneeskunde (Departement)
Lid
Vanaf1 okt 2018 → 31 dec 2020 - Vakgroep Biochemie (Departement)
Lid
Vanaf1 feb 2014 → 30 sep 2018 - Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 mei 2006 → 31 jan 2014 - Vakgroep Plantenbiotechnologie en Bio-informatica (Departement)
Lid
Vanaf1 jan 1993 → 30 sep 1995
Publicaties
1 - 10 van 23
- A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state(2023)
Auteurs: Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, Niels Vandamme, Stephane Plaisance, Annick Verhee, Dominiek Catteeuw, Elke Rogge, Jennifer De Geest, Nele Vanderroost, et al.
- Microcirculatory function during endotoxemia : a functional citrulline-arginine-NO pathway and NOS3 complex is essential to maintain the microcirculation(2021)
Auteurs: Karolina A. P. Wijnands, Dennis M. Meesters, Benjamin Vandendriessche, Jacob J. Briede, Hans M. H. van Eijk, Peter Brouckaert, Anje Cauwels, Wouter H. Lamers, Martijn Poeze
- Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE(2021)
Auteurs: Anje Cauwels, Elke Rogge, Shengru Pang, Marco Prinz, Niko Kley, Gilles Uze, Jan Tavernier
- Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice(2019)
Auteurs: Anje Cauwels, Sandra Van Lint, Dominiek Catteeuw, Shengru Pang, Franciane Paul, Elke Rogge, Annick Verhee, Marco Prinz, Niko Kley, Gilles Uzé, et al.
Pagina's: 70 - 76 - Citrulline supplementation improves organ perfusion and arginine availability under conditions with enhanced arginase activity(2015)
Auteurs: Karolina AP Wijnands, Dennis M Meesters, Kevin WY van Barneveld, Ruben GJ Visschers, Jacob J Briedé, Benjamin Vandendriessche, Hans MH van Eijk, Babs AFM Bessems, Nadine van den Hoven, Christian JH von Wintersdorff, et al.
Pagina's: 5217 - 5238 - Nitric oxide production by endotoxin preparations in TLR4-deficient mice(2014)
Auteurs: Anje Cauwels, Jennyfer Bultinck, Renske De Zwaef, Benjamin Vandendriessche, Stefan Magez, Peter Brouckaert
Pagina's: 36 - 43 - Extracellular ATP drives systemic inflammation, tissue damage and mortality(2014)
Auteurs: Anje Cauwels, Elke Rogge, Benjamin Vandendriessche, S Shiva, Peter Brouckaert
- A multiscale entropy-based tool for scoring severity of systemic inflammation(2014)
Auteurs: Benjamin Vandendriessche, Harlinde Peperstraete, Elke Rogge, Peter Cauwels, Oliver Stiedl, Peter Brouckaert, Anje Cauwels
Pagina's: E560 - E569 - MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock(2014)
Auteurs: Benjamin Vandendriessche, An Goethals, Alba Simats, Evelien Van Hamme, Peter Brouckaert, Anje Cauwels
- Of mice, men, and inflammation(2013)
Auteurs: Anje Cauwels, Benjamin Vandendriessche, Peter Brouckaert
Pagina's: E3150 - E3150
Patenten
1 - 10 van 10
- CD8 BINDING AGENTS (Inventor)
- MODULATION OF DENDRITIC CELL LINEAGES (Inventor)
- CLEC9A BINDING AGENTS AND USE THEREOF (Inventor)
- FIBROBLAST BINDING AGENTS AND USE THEREOF (Inventor)
- MODULATION OF DENDRITIC CELL LINEAGES (Inventor)
- FIBROBLAST BINDING AGENTS AND USE THEREOF (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- THERAPEUTIC TARGETING OF NON-CELLULAR ANTIGENS (Inventor)
- CLEC9A BINDING AGENTS AND USE THEREOF (Inventor)
- BISPECIFIC SIGNALING AGENT AND USES THEREOF (Inventor)